Amgen will buy you guys

Quote






I've been at Onyx 5 years, and love the company. I haven't looked at Cafe Pharma in years, but decided to see what people are saying. Now I remember why I don't look at it... It looks like 90% of the posts are from bitter, unsuccessful employees or ex-employees, and anyone who is jealous of those who made it to the top of the ladder (that would not be me). Just because someone else is making money on an acquisition and you are not, does not make them stupid. Maybe they're not smarter than you, but they made some better choices somewhere along the way than you did.Onyx management has done an amazing job. Tony Coles and his team have turned the company from a one trick pony into a valuable company with good drugs on the market and a very tasty pipeline ripe for plucking by a big pharma with patent expirations everywhere they look. Thanks Tony and Juergen for transforming the company! I'm looking forward to my retirement when the company is acquired! I haven't sold any options since joining the company. Even in my lowly position, it adds up nicely!
 






Very nice post old timer. I wish you the best in your retirement if and when we do get acquired. I am very new to Onyx so by definition don't stand to gain much but couldn't be happier for the folks that stayed on through good times and bad and now look forward to cashing in. Hopefully everyone gets something and ends up in a better position than when they started.
 






Anonymous said:
I've been at Onyx 5 years, and love the company. I haven't looked at Cafe Pharma in years, but decided to see what people are saying. Now I remember why I don't look at it... It looks like 90% of the posts are from bitter, unsuccessful employees or ex-employees, and anyone who is jealous of those who made it to the top of the ladder (that would not be me). Just because someone else is making money on an acquisition and you are not, does not make them stupid. Maybe they're not smarter than you, but they made some better choices somewhere along the way than you did.Onyx management has done an amazing job. Tony Coles and his team have turned the company from a one trick pony into a valuable company with good drugs on the market and a very tasty pipeline ripe for plucking by a big pharma with patent expirations everywhere they look. Thanks Tony and Juergen for transforming the company! I'm looking forward to my retirement when the company is acquired! I haven't sold any options since joining the company. Even in my lowly position, it adds up nicely!
Click to expand...


Please, stop the suck up. This whole scenario is based on equal parts luck and equal parts skill.
Sometimes smart people get rich and sometimes not so smart people get rich, luck and relationships have everything to do with it. Tony and his team have been both smart and lucky...they missed their original filing date by over a year with Kyprolis, since we didnt have a clue what we were doing (manufacturing anyone...) and we got our asses handed to us with the Bayer settlement. That was not a win for the KI commercial team, but a trust fund for the company...thus, lucky for PRI and all employees. The board is selling us because it is the right thing for shareholders, and because they do not have the money or skill to go it alone. There are plenty of reps and others who have barely worked on KI side and have been sitting back waiting for this buyout. There is nothing to be done about it, those folks are just damn lucky. A profitable choice yes, but honorable...no way!!! This is just life guys, it is not fair, but hopefully it balances out in the end. No need to cater to over-inflated egos or to those who are just lucky. But take solace in knowing that just as some dumbasses are winning the Onyx lottery so are some really good people....which one are you? I know who and what I am.
 






Anonymous said:
I've been at Onyx 5 years, and love the company. I haven't looked at Cafe Pharma in years, but decided to see what people are saying. Now I remember why I don't look at it... It looks like 90% of the posts are from bitter, unsuccessful employees or ex-employees, and anyone who is jealous of those who made it to the top of the ladder (that would not be me). Just because someone else is making money on an acquisition and you are not, does not make them stupid. Maybe they're not smarter than you, but they made some better choices somewhere along the way than you did.Onyx management has done an amazing job. Tony Coles and his team have turned the company from a one trick pony into a valuable company with good drugs on the market and a very tasty pipeline ripe for plucking by a big pharma with patent expirations everywhere they look. Thanks Tony and Juergen for transforming the company! I'm looking forward to my retirement when the company is acquired! I haven't sold any options since joining the company. Even in my lowly position, it adds up nicely!
Click to expand...

Now go back and do your job mds rep or whatever you do other than talk a good talk. The snakes are crawling out of the rocks to join the party. You sound stupid but lucky to be here at your first biooncology company.
 






Anonymous said:
Now go back and do your job mds rep or whatever you do other than talk a good talk. The snakes are crawling out of the rocks to join the party. You sound stupid but lucky to be here at your first biooncology company.
Click to expand...

I'll take my "stupid but lucky" (and happy, and hard working, and appreciative of the chances I've been given, rather than sound like a whiney, sore, loser. Keep it up! With your attitude I'm sure you'll be a great success! LOL
 






Anonymous said:
Please, stop the suck up. This whole scenario is based on equal parts luck and equal parts skill.
Sometimes smart people get rich and sometimes not so smart people get rich, luck and relationships have everything to do with it. Tony and his team have been both smart and lucky...they missed their original filing date by over a year with Kyprolis, since we didnt have a clue what we were doing (manufacturing anyone...) and we got our asses handed to us with the Bayer settlement. That was not a win for the KI commercial team, but a trust fund for the company...thus, lucky for PRI and all employees. The board is selling us because it is the right thing for shareholders, and because they do not have the money or skill to go it alone. There are plenty of reps and others who have barely worked on KI side and have been sitting back waiting for this buyout. There is nothing to be done about it, those folks are just damn lucky. A profitable choice yes, but honorable...no way!!! This is just life guys, it is not fair, but hopefully it balances out in the end. No need to cater to over-inflated egos or to those who are just lucky. But take solace in knowing that just as some dumbasses are winning the Onyx lottery so are some really good people....which one are you? I know who and what I am.
Click to expand...

I agree with your points. Not sure why you have to call me a suck up because I'm appreciative of the opportunities I've been given. I work hard, made good (and lucky) choices. I also can see the management team is good, at least from my perspective. I'm not in commercial, so don't know your point of view.
 






Anonymous said:
Now go back and do your job mds rep or whatever you do other than talk a good talk. The snakes are crawling out of the rocks to join the party. You sound stupid but lucky to be here at your first biooncology company.
Click to expand...

Awwww, you poor child. You've obviously been the victim of evil Onyx. Come on now... pull on your big girl panties and try to get over it. Maybe you'll have better "luck" next time. Or the time after that. Or the time after that.
 




































Anonymous said:
Oh you must have wussed out at $135 or better yet some of you who jumped in the 80's and 90's hahahahahahaha...so now you are hoping we don't get sold or we sell for less than $135 so you don't look like an dummy...
Click to expand...

O no way, I am taking my investment advise from Cafepharma and am going to ride this sucker to the top. Some say $165, well I say that is too low and that we shouldn't even entertain offers for less than $200.
 












Anonymous said:
O no way, I am taking my investment advise from Cafepharma and am going to ride this sucker to the top. Some say $165, well I say that is too low and that we shouldn't even entertain offers for less than $200.
Click to expand...

No, but I’m sure you’re taking your investment cues from Yahoo Finance and their ‘Message Board’ morons, Seeking Alpha, and Motley Fool, not realizing that they are blogs written by bloggers not actual financial journalists or analysts…Might not be $200 but it will be a lot closer to $165…not to worry as I’m sure that $30 a share is just a drop in the bucket for you.
 






Anonymous said:
No, but I’m sure you’re taking your investment cues from Yahoo Finance and their ‘Message Board’ morons, Seeking Alpha, and Motley Fool, not realizing that they are blogs written by bloggers not actual financial journalists or analysts…Might not be $200 but it will be a lot closer to $165…not to worry as I’m sure that $30 a share is just a drop in the bucket for you.
Click to expand...

I would really like to know just how you are coming up with this price of $165? I can't see it but am hoping you are right.
 






Anonymous said:
I would really like to know just how you are coming up with this price of $165? I can't see it but am hoping you are right.
Click to expand...

Did you think we’d see $136 a month ago? Did you think we’d turn down $120 a share a month ago? Heavy investors are still buying in the $130’s…they’re not buying in to be sold at $140. If $120 was ‘substantially undervalued’ in TC’s mind $140 is not ‘accurately valued’. There are many different ways to do company valuations especially in biotech which has less to do with current revenue models but prospective models. Biotech like the tech industry is the second coming of the gold rush…it’s all based on speculation. Does Alexion’s mkt cap make any sense based on their revenue when using traditional valuations? Of course not. We’ve all read the same reports that say Amgen’s $120 was an over bid and we’ve read that ONXX could fetch as much as $180-$200. Since it’s all over the place I would say that noting is out of question at this point.

My understanding is that a 16% increase from the Amgen offer of $120, that TC scoffed at, is not going to get it done so scratch $140 off the board. If $140 is not going to get it done let’s bump it up to $150 a share which is a 25% increase from Amgen’s $120 a share. So let’s say that TC thought that Amgen’s offer was 25% undervalued, which I believe would be the minimum percentage break point for being undervalued. That brings the fair market value, in TC’s mind to $150. Add in multiple bidders and you can throw on another 10% premium due to up bids. That is how I come to $165.

Lastly if the market thought we weren’t selling and if the market thought we weren’t selling north of $150 we would have seen the pull back and NO going from $136.87 to the low close of $131.17 is not a pullback, that is risk adverse profit taking which is fine and expected. Pullback would be if you saw our big institutional investors dumping which has not happened.
 






Anonymous said:
No, but I’m sure you’re taking your investment cues from Yahoo Finance and their ‘Message Board’ morons, Seeking Alpha, and Motley Fool, not realizing that they are blogs written by bloggers not actual financial journalists or analysts…Might not be $200 but it will be a lot closer to $165…not to worry as I’m sure that $30 a share is just a drop in the bucket for you.
Click to expand...

I hope you are hanging on to those shares now that Pfizer has decided to back out of the bidding. I am not thinking $165 is looking too good. But what do I know, you sir are the wizard of wall street!
 












Top Bottom
Back
Quote